Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Common Equity (2016 - 2025)

Historic Common Equity for Innovate (VATE) over the last 17 years, with Q3 2025 value amounting to -$233.3 million.

  • Innovate's Common Equity fell 6534.37% to -$233.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$233.3 million, marking a year-over-year decrease of 6534.37%. This contributed to the annual value of -$180.4 million for FY2024, which is 1891.89% down from last year.
  • Innovate's Common Equity amounted to -$233.3 million in Q3 2025, which was down 6534.37% from -$224.8 million recorded in Q2 2025.
  • Innovate's 5-year Common Equity high stood at $511.5 million for Q2 2021, and its period low was -$233.3 million during Q3 2025.
  • Its 5-year average for Common Equity is -$70.4 million, with a median of -$126.1 million in 2024.
  • As far as peak fluctuations go, Innovate's Common Equity skyrocketed by 58347.11% in 2021, and later tumbled by 11675.94% in 2022.
  • Over the past 5 years, Innovate's Common Equity (Quarter) stood at -$56.2 million in 2021, then crashed by 61.21% to -$90.6 million in 2022, then crashed by 67.44% to -$151.7 million in 2023, then decreased by 18.92% to -$180.4 million in 2024, then fell by 29.32% to -$233.3 million in 2025.
  • Its Common Equity was -$233.3 million in Q3 2025, compared to -$224.8 million in Q2 2025 and -$204.2 million in Q1 2025.